Mentions:
1: Christian Wakeford (Lab - Bury South) scandal, the Cumberlege report highlighted over three years ago the need for redress for victims of the sodium - Speech Link
Written Evidence Apr. 24 2024
Inquiry: NHS leadership, performance and patient safetyFound: , includes the number of whistleblowing disclosures received by the GPhC and any action taken.18 Sodium
Written Evidence Apr. 24 2024
Inquiry: NHS leadership, performance and patient safetyFound: the Infected Blood Scandal, and gross injustice for those who have suffered in the Mesh Implant & Sodium
Written Evidence Apr. 24 2024
Inquiry: NHS leadership, performance and patient safetyFound: Residential care - Winterbourne View and Whorlton Hall Medicines and medical devices – Primodos, Sodium
Asked by: Siobhan Baillie (Conservative - Stroud)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to The Hughes Report, published by the Patient Safety Commissioner on 7 February 2024, if she will ensure that people impacted by bowel mesh are eligible for financial redress.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course. Bowel mesh, also known as rectopexy mesh, did not fall within the definition of pelvic organ prolapse that the PSC investigated for her report.
Asked by: Siobhan Baillie (Conservative - Stroud)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what her Department's timescales are for responding to The Hughes Report, published by the Patient Safety Commissioner on 7 February 2024.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations and will respond substantively in due course. Bowel mesh, also known as rectopexy mesh, did not fall within the definition of pelvic organ prolapse that the PSC investigated for her report.
Mentions:
1: Christian Wakeford (Lab - Bury South) For example, the sodium valproate issue was raised through Baroness Cumberlege’s “First Do No Harm” report - Speech Link
2: Christian Wakeford (Lab - Bury South) Moving back to the sodium valproate scandal, we keep saying that justice delayed is justice denied, but - Speech Link
3: Christopher Chope (Con - Christchurch) Member for North Durham (Mr Jones) said, and in the sodium valproate case, which has given rise to huge - Speech Link
4: Sharon Hodgson (Lab - Washington and Sunderland West) valproate and Primodos. - Speech Link
Asked by: Andrew Selous (Conservative - South West Bedfordshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when her Department plans to make a decision on financial redress for those harmed by pelvic mesh or sodium valproate.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Government commissioned the Patient Safety Commissioner to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the Commissioner and her team for completing this report and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the Commissioner’s recommendations and will respond substantively in due course.
Asked by: Justin Madders (Labour - Ellesmere Port and Neston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what her planned timetable is for publishing a response to the Hughes Report on compensation for patients damaged by sodium valproate, published 7 February 2024.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations, and will respond substantively in due course.
Apr. 09 2024
Source Page: MHRA FOI performance dataFound: Valproate b) Carbamazepine c) Topiramate d) Levetiracetam e) Lamotrigine f) Pregabalin g) Phenytoin